Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal
Clinical trial NCT07223476 · COMPLETED
Trial details
- NCT number
- NCT07223476
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-29
- Primary completion
- 2024-07-01
- Enrollment
- 1926
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.